Purpose: Oral supplementation with omega 3 (ω-3) and/or 6 (ω-6) fatty acids (FAs) has been
reported to alleviate the signs and symptoms of dry eye disease and to improve the …

Purpose Blepharitis and meibomian gland dysfunction (MGD) are common sources of
complaints from patients. To evaluate the effect on ocular symptoms, ocular findings, and …

To investigate the effect of ω-3 fatty acids on human meibomian gland epithelial cells
(HMGECs, cell line) in vitro. HMGECs were stimulated with docosahexaenoic acid (DHA) or …

Purpose: To investigate the potential effect of dietary supplementation with omega-3 fatty
acid on lipid composition of meibum, aqueous tear evaporation, and tear volume in patients …

Purpose The molecular basis of the tear film and lipid layer alterations in meibomian gland
dysfunction (MGD) is unknown. This study aimed to identify and compare (O-acyl)-omega …

Dry eye is a common inflammatory condition of the ocular surface. While oral omega-3
supplementation for its treatment has been extensively studied, recent large-scale studies …

Background Dysfunction of the meibomian gland (MG) is among the most frequent causes of
ophthalmological symptoms. The inflammation seen in meibomian gland dysfunction (MGD) …

Purpose To evaluate the relationship between omega-3 (n-3) and omega-6 (n-6) fatty acids
with dry eye disease (DED) and meibomian gland dysfunction (MGD). Design Cross …

Exocrine Meibomian glands (MG) play a central role in the ocular surface physiology by
producing meibum–a lipid secretion composed of cholesteryl esters (CE), cholesterol (Chl) …

Purpose: To assess the effect of oral re-esterified omega-3 fatty acids on tear osmolarity,
matrix metalloproteinase-9 (MMP-9), tear break-up time (TBUT), Ocular Surface Disease …